Ubs Group Ag CARISMA THERAPEUTICS INC Transaction History

Ubs Group Ag

  • $555 Billion
  • Q2 2025
Number of Shares
22,105
Previous 3,077 618.39%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
N/A
19,028 Added 618.39%
22,105 $0
Q1 2025

May 13, 2025
SELL
N/A
-21,224 Reduced 87.34%
3,077 $0
Q4 2024

Feb 14, 2025
BUY
N/A
24,083 Added 11047.25%
24,301 $0
Q3 2024

Nov 14, 2024
SELL
N/A
-6 Reduced 2.68%
218 $0
Q2 2024

Aug 13, 2024
SELL
N/A
-26,979 Reduced 99.18%
224 $0
Q1 2024

May 13, 2024
SELL
N/A
-2,256 Reduced 7.66%
27,203 $0
Q4 2023

Feb 09, 2024
BUY
N/A
14,634 Added 98.71%
29,459 $0
Q3 2023

Nov 09, 2023
SELL
N/A
-578 Reduced 3.75%
14,825 $0
Q2 2023

Aug 11, 2023
BUY
N/A
15,381 Added 69913.64%
15,403 $0
Q1 2023

May 12, 2023
BUY
N/A
22 New
22 $0
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email